Literature DB >> 29738669

CypReact: A Software Tool for in Silico Reactant Prediction for Human Cytochrome P450 Enzymes.

Siyang Tian1,2, Yannick Djoumbou-Feunang3, Russell Greiner1,2, David S Wishart1,3.   

Abstract

In silico metabolism prediction requires first predicting whether a specific molecule will interact with one or more specific metabolizing enzymes, then predicting the result of each enzymatic reaction. Here, we provide a computational tool, CypReact, for performing this first task of reactant prediction. Specifically, CypReact takes as input an arbitrary molecule (specified as a SMILES string or a standard SDF file) and any one of the nine of the most important human cytochrome P450 (CYP450) enzymes-CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP2E1, or CYP3A4-and accurately predicts whether the query molecule will react with that given CYP450 enzyme. Tests of CypReact, conducted over a data set of 1632 molecules (each considered a "plausible" reactant) show that it is very effective, with a (cross-validation) AUROC (area under the receiver operating characteristic curve) of 0.83-0.92. We also show that CypReact performs significantly better than other reactant prediction tools such as ADMET Predictor and (a reactant-predicting extension of) SMARTCyp, whose average AUROCs are 0.75 and 0.53, respectively. We then applied the learned CypReact models to a previously unseen set of molecules and found that our CypReact did even better and still significantly surpassed the performance of SMARTCyp and ADMET Predictor. These results suggest that CypReact could be an important component of a suite of in silico metabolism prediction tools for accurately predicting the products of Phase I, Phase II, and microbial metabolism in humans. CypReact is available at https://bitbucket.org/Leon_Ti/cypreact .

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29738669     DOI: 10.1021/acs.jcim.8b00035

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  11 in total

1.  In Silico Tools and Software to Predict ADMET of New Drug Candidates.

Authors:  Supratik Kar; Kunal Roy; Jerzy Leszczynski
Journal:  Methods Mol Biol       Date:  2022

2.  Impact of Established and Emerging Software Tools on the Metabolite Identification Landscape.

Authors:  Anne Marie E Smith; Kiril Lanevskij; Andrius Sazonovas; Jesse Harris
Journal:  Front Toxicol       Date:  2022-06-21

3.  CyProduct: A Software Tool for Accurately Predicting the Byproducts of Human Cytochrome P450 Metabolism.

Authors:  Siyang Tian; Xuan Cao; Russell Greiner; Carin Li; AnChi Guo; David S Wishart
Journal:  J Chem Inf Model       Date:  2021-05-26       Impact factor: 6.162

4.  BioTransformer 3.0-a web server for accurately predicting metabolic transformation products.

Authors:  David S Wishart; Siyang Tian; Dana Allen; Eponine Oler; Harrison Peters; Vicki W Lui; Vasuk Gautam; Yannick Djoumbou-Feunang; Russell Greiner; Thomas O Metz
Journal:  Nucleic Acids Res       Date:  2022-05-10       Impact factor: 19.160

Review 5.  Computational methods and tools to predict cytochrome P450 metabolism for drug discovery.

Authors:  Jonathan D Tyzack; Johannes Kirchmair
Journal:  Chem Biol Drug Des       Date:  2019-01-15       Impact factor: 2.817

Review 6.  Artificial Intelligence in Drug Discovery: A Comprehensive Review of Data-driven and Machine Learning Approaches.

Authors:  Hyunho Kim; Eunyoung Kim; Ingoo Lee; Bongsung Bae; Minsu Park; Hojung Nam
Journal:  Biotechnol Bioprocess Eng       Date:  2021-01-07       Impact factor: 3.386

Review 7.  Quo vadis blood protein adductomics?

Authors:  Gabriele Sabbioni; Billy W Day
Journal:  Arch Toxicol       Date:  2021-11-13       Impact factor: 5.153

8.  XenoNet: Inference and Likelihood of Intermediate Metabolite Formation.

Authors:  Noah R Flynn; Na Le Dang; Michael D Ward; S Joshua Swamidass
Journal:  J Chem Inf Model       Date:  2020-06-29       Impact factor: 4.956

Review 9.  Descriptors of Cytochrome Inhibitors and Useful Machine Learning Based Methods for the Design of Safer Drugs.

Authors:  Tyler C Beck; Kyle R Beck; Jordan Morningstar; Menny M Benjamin; Russell A Norris
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-17

Review 10.  Machine learning models for classification tasks related to drug safety.

Authors:  Anita Rácz; Dávid Bajusz; Ramón Alain Miranda-Quintana; Károly Héberger
Journal:  Mol Divers       Date:  2021-06-10       Impact factor: 3.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.